FEBS J:艾滋病新突破,CRISPR基因编辑技术再立一大功艾滋病新突破,CRISPR基因编辑技术再立一大功

2017-11-08 Heather_z727 来宝网

在对抗艾滋病的道路上,全世界的科学家们一直在努力着,这些年来,对抗艾滋病的疗法也取得了很大的进展。艾滋病之所以可怕是因为艾滋病毒会通过摧毁人类的免疫系统而伤害感染者的身体,感染艾滋病毒的患者基本上都不是因为艾滋病毒而死,而是由于残缺的免疫系统使他们变得“遍体鳞伤”。据研究,艾滋病毒会感染大脑中的某些细胞,这些细胞是小胶质细胞,同时,被感染的小胶质细胞释放有毒和炎性分子,削弱或杀死周围的神经元,引起

新模型对艾滋病毒引起的神经认知障碍提供新见解】在对抗艾滋病的道路上,全世界的科学家们一直在努力着,这些年来,对抗艾滋病的疗法也取得了很大的进展。艾滋病之所以可怕是因为艾滋病毒会通过摧毁人类的免疫系统而伤害感染者的身体,感染艾滋病毒的患者基本上都不是因为艾滋病毒而死,而是由于残缺的免疫系统使他们变得“遍体鳞伤”。据研究,艾滋病毒会感染大脑中的某些细胞,这些细胞是小胶质细胞,同时,被感染的小胶质细胞释放有毒和炎性分子,削弱或杀死周围的神经元,引起神经认知障碍的问题。

长久以来,研究人员一直在寻找方法,了解艾滋病毒引起的神经认知障碍,然而,始终没有大的进展,研究人员对于艾滋病病毒和小胶质细胞作用的了解非常有限。然而,最新发表的一项研究提供了新的见解,在新的研究中,科学人员使用CRISPR / Cas9基因编辑技术,开发了一种新型的艾滋病毒感染小胶质细胞模型。

模型将用于开发抗艾滋病病毒的治疗新方法,了解HIV感染对大脑的损害。

研究人员在报告中表示:“在此次研究中,我们运用CRISPR / Cas9基因编辑技术所设计的新模型,有助于我们了解由艾滋病毒引起的神经认知障碍,这一发现将会带来治疗艾滋病的新策略。”

原始出处:

Lee A. Campbell, Christopher T. Richie, Yajun Zhang, et al. In vitro modeling of HIV proviral activity in microglia. The FEBS Journal First Published: 8 November 2017.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1724957, encodeId=b66b1e2495703, content=<a href='/topic/show?id=9ee758586bb' target=_blank style='color:#2F92EE;'>#新突破#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58586, encryptionId=9ee758586bb, topicName=新突破)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=792a33728807, createdName=zxxiang, createdTime=Mon Mar 12 13:41:00 CST 2018, time=2018-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1744372, encodeId=f1ef1e44372a6, content=<a href='/topic/show?id=42a7523823' target=_blank style='color:#2F92EE;'>#CRISPR基因编辑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5238, encryptionId=42a7523823, topicName=CRISPR基因编辑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e1c35375117, createdName=guguangxiang, createdTime=Sat Mar 10 02:41:00 CST 2018, time=2018-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276054, encodeId=607b12e60541f, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5211, encryptionId=755d5211a0, topicName=CRISPR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Fri Nov 10 14:41:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630155, encodeId=82311630155cf, content=<a href='/topic/show?id=d81a4186e3f' target=_blank style='color:#2F92EE;'>#基因编辑技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41867, encryptionId=d81a4186e3f, topicName=基因编辑技术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a10c21466636, createdName=marlenexl, createdTime=Fri Nov 10 14:41:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260035, encodeId=bbcd26003563, content=学习学习.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Thu Nov 09 18:32:39 CST 2017, time=2017-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=259840, encodeId=b8412598404a, content=学习了很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Thu Nov 09 00:23:25 CST 2017, time=2017-11-09, status=1, ipAttribution=)]
    2018-03-12 zxxiang
  2. [GetPortalCommentsPageByObjectIdResponse(id=1724957, encodeId=b66b1e2495703, content=<a href='/topic/show?id=9ee758586bb' target=_blank style='color:#2F92EE;'>#新突破#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58586, encryptionId=9ee758586bb, topicName=新突破)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=792a33728807, createdName=zxxiang, createdTime=Mon Mar 12 13:41:00 CST 2018, time=2018-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1744372, encodeId=f1ef1e44372a6, content=<a href='/topic/show?id=42a7523823' target=_blank style='color:#2F92EE;'>#CRISPR基因编辑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5238, encryptionId=42a7523823, topicName=CRISPR基因编辑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e1c35375117, createdName=guguangxiang, createdTime=Sat Mar 10 02:41:00 CST 2018, time=2018-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276054, encodeId=607b12e60541f, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5211, encryptionId=755d5211a0, topicName=CRISPR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Fri Nov 10 14:41:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630155, encodeId=82311630155cf, content=<a href='/topic/show?id=d81a4186e3f' target=_blank style='color:#2F92EE;'>#基因编辑技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41867, encryptionId=d81a4186e3f, topicName=基因编辑技术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a10c21466636, createdName=marlenexl, createdTime=Fri Nov 10 14:41:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260035, encodeId=bbcd26003563, content=学习学习.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Thu Nov 09 18:32:39 CST 2017, time=2017-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=259840, encodeId=b8412598404a, content=学习了很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Thu Nov 09 00:23:25 CST 2017, time=2017-11-09, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1724957, encodeId=b66b1e2495703, content=<a href='/topic/show?id=9ee758586bb' target=_blank style='color:#2F92EE;'>#新突破#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58586, encryptionId=9ee758586bb, topicName=新突破)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=792a33728807, createdName=zxxiang, createdTime=Mon Mar 12 13:41:00 CST 2018, time=2018-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1744372, encodeId=f1ef1e44372a6, content=<a href='/topic/show?id=42a7523823' target=_blank style='color:#2F92EE;'>#CRISPR基因编辑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5238, encryptionId=42a7523823, topicName=CRISPR基因编辑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e1c35375117, createdName=guguangxiang, createdTime=Sat Mar 10 02:41:00 CST 2018, time=2018-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276054, encodeId=607b12e60541f, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5211, encryptionId=755d5211a0, topicName=CRISPR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Fri Nov 10 14:41:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630155, encodeId=82311630155cf, content=<a href='/topic/show?id=d81a4186e3f' target=_blank style='color:#2F92EE;'>#基因编辑技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41867, encryptionId=d81a4186e3f, topicName=基因编辑技术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a10c21466636, createdName=marlenexl, createdTime=Fri Nov 10 14:41:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260035, encodeId=bbcd26003563, content=学习学习.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Thu Nov 09 18:32:39 CST 2017, time=2017-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=259840, encodeId=b8412598404a, content=学习了很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Thu Nov 09 00:23:25 CST 2017, time=2017-11-09, status=1, ipAttribution=)]
    2017-11-10 yuandd
  4. [GetPortalCommentsPageByObjectIdResponse(id=1724957, encodeId=b66b1e2495703, content=<a href='/topic/show?id=9ee758586bb' target=_blank style='color:#2F92EE;'>#新突破#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58586, encryptionId=9ee758586bb, topicName=新突破)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=792a33728807, createdName=zxxiang, createdTime=Mon Mar 12 13:41:00 CST 2018, time=2018-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1744372, encodeId=f1ef1e44372a6, content=<a href='/topic/show?id=42a7523823' target=_blank style='color:#2F92EE;'>#CRISPR基因编辑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5238, encryptionId=42a7523823, topicName=CRISPR基因编辑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e1c35375117, createdName=guguangxiang, createdTime=Sat Mar 10 02:41:00 CST 2018, time=2018-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276054, encodeId=607b12e60541f, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5211, encryptionId=755d5211a0, topicName=CRISPR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Fri Nov 10 14:41:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630155, encodeId=82311630155cf, content=<a href='/topic/show?id=d81a4186e3f' target=_blank style='color:#2F92EE;'>#基因编辑技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41867, encryptionId=d81a4186e3f, topicName=基因编辑技术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a10c21466636, createdName=marlenexl, createdTime=Fri Nov 10 14:41:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260035, encodeId=bbcd26003563, content=学习学习.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Thu Nov 09 18:32:39 CST 2017, time=2017-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=259840, encodeId=b8412598404a, content=学习了很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Thu Nov 09 00:23:25 CST 2017, time=2017-11-09, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1724957, encodeId=b66b1e2495703, content=<a href='/topic/show?id=9ee758586bb' target=_blank style='color:#2F92EE;'>#新突破#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58586, encryptionId=9ee758586bb, topicName=新突破)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=792a33728807, createdName=zxxiang, createdTime=Mon Mar 12 13:41:00 CST 2018, time=2018-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1744372, encodeId=f1ef1e44372a6, content=<a href='/topic/show?id=42a7523823' target=_blank style='color:#2F92EE;'>#CRISPR基因编辑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5238, encryptionId=42a7523823, topicName=CRISPR基因编辑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e1c35375117, createdName=guguangxiang, createdTime=Sat Mar 10 02:41:00 CST 2018, time=2018-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276054, encodeId=607b12e60541f, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5211, encryptionId=755d5211a0, topicName=CRISPR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Fri Nov 10 14:41:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630155, encodeId=82311630155cf, content=<a href='/topic/show?id=d81a4186e3f' target=_blank style='color:#2F92EE;'>#基因编辑技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41867, encryptionId=d81a4186e3f, topicName=基因编辑技术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a10c21466636, createdName=marlenexl, createdTime=Fri Nov 10 14:41:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260035, encodeId=bbcd26003563, content=学习学习.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Thu Nov 09 18:32:39 CST 2017, time=2017-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=259840, encodeId=b8412598404a, content=学习了很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Thu Nov 09 00:23:25 CST 2017, time=2017-11-09, status=1, ipAttribution=)]
    2017-11-09 1dd8c52fm63(暂无匿称)

    学习学习.继续关注

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1724957, encodeId=b66b1e2495703, content=<a href='/topic/show?id=9ee758586bb' target=_blank style='color:#2F92EE;'>#新突破#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58586, encryptionId=9ee758586bb, topicName=新突破)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=792a33728807, createdName=zxxiang, createdTime=Mon Mar 12 13:41:00 CST 2018, time=2018-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1744372, encodeId=f1ef1e44372a6, content=<a href='/topic/show?id=42a7523823' target=_blank style='color:#2F92EE;'>#CRISPR基因编辑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5238, encryptionId=42a7523823, topicName=CRISPR基因编辑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e1c35375117, createdName=guguangxiang, createdTime=Sat Mar 10 02:41:00 CST 2018, time=2018-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276054, encodeId=607b12e60541f, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5211, encryptionId=755d5211a0, topicName=CRISPR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Fri Nov 10 14:41:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630155, encodeId=82311630155cf, content=<a href='/topic/show?id=d81a4186e3f' target=_blank style='color:#2F92EE;'>#基因编辑技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41867, encryptionId=d81a4186e3f, topicName=基因编辑技术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a10c21466636, createdName=marlenexl, createdTime=Fri Nov 10 14:41:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260035, encodeId=bbcd26003563, content=学习学习.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Thu Nov 09 18:32:39 CST 2017, time=2017-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=259840, encodeId=b8412598404a, content=学习了很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Thu Nov 09 00:23:25 CST 2017, time=2017-11-09, status=1, ipAttribution=)]
    2017-11-09 飛歌

    学习了很有用

    0

相关资讯

Cell Che Biol:艾滋病可以说是有救了,科学实验显示出希望

马里兰大学(UniversityofMaryland)和杜克大学(DukeUniversity)的研究人员设计了一种新型的蛋白质-糖疫苗候选疫苗,在一种动物模型中,它刺激了免疫系统对HIV病毒的免疫反应。有朝一日,这种分子可能成为成功的艾滋病疫苗的一部分。

NEJM:新研究指出,艾滋病大流行即将卷土重来

自从60年代中期开始,强大的药物使艾滋病大流行得到了很好的控制,但现在一个专家小组警告说,全球艾滋病毒流行风险持续扩大。

J Positive Sexual:年轻男性艾滋病感染人数创新高,原因是什么?

美国疾病控制和预防中心最近发布数据表示,年轻黑人男性艾滋病人数仍未得到控制,范德比尔特的研究人员正在建设安全空间,帮助年轻黑人男性抑制艾滋病毒流行。

上海:HIV快检试剂可在药店购买

近日从上海市卫生计生委获悉,上海市已启动HIV唾液快检试剂药店销售试点工作,市民可在试点药店购买HIV唾液快检试剂,方便、快速地进行HIV抗体检测。

MMWR:为什么女性艾滋病感染人数总是居高不下?

近日,在线发表于《发病率与死亡率》杂志上的一项研究表示,很高比例的女性艾滋病感染者在确诊感染之后,没有接受治疗,这一结果可能就是长期以来,女性艾滋病感染人数居高不下的原因之一。

黑龙江艾滋病检测将入婚检

《黑龙江省遏制与防治艾滋病“十三五”行动计划》于日前出台。